Evidence-based nursing practice about risk of adverse drug interaction in icu – systematic review

Cassia Amorim Rodrigues Araújo, Isabel Cristina Fonseca da Cruz

Abstract


Abstract: This study analyzed the risks of adverse drug interactions based on updated scientific evidence, through the intensive care team, within a maximum of 7 days of hospitalization. Methods: This is a systematic review of the literature through the search for online data from 2012 to 2019. Through evidence-based practices on adverse drug interactions in intensive care units, using a PICOT strategy. Results: 10 publications were analyzed using the thematic analysis technique, in which 2 categories emerged: Risk of drug interactions associated with the number of drugs prescribed, highlighting the high number of medications administered simultaneously and the importance of the multidisciplinary team for patient safety linked to the need for professional updating and effective communication between the group. Conclusion: The identification of a significant number of drug interactions stands out in the highly complex patient, and this number increases when it comes to the adult / elderly person due to the number of drugs already pre-existing in their therapy. Current evidence addresses that communication between the multidisciplinary team, coupled with the installation of protocols, flowcharts and rescheduling of medications can be a facilitating component for patient safety, preventing adverse events.
Keywords: Drug interactions; Intensive Care Units; Patient safety; Nursing care.

Keywords


Heart failure, nursing diagnosis; nursing care; critical specialized nursing; watch out; nursing

Full Text:

HTML

References


Teles CMS, Oliveira JCS, Aoyama EA. Fatores de risco durante a utilização de medicamentos na unidade de terapia intensiva. ReBIS [Internet]. 2019 [cited 2020 ago 29]; 1(4):44-9. Available from: http://revista.rebis.com.br/index.php/rebis/article/view/239/80

Moreira MB, Mesquita MGR, Stipp MAC, Paes GO. Potenciais interações de medicamentos intravenosos em terapia intensiva. Rev Esc Enferm USP [Internet]. 2017 [cited 2020 ago 29]; 51(e03233):1-8. Available from: https://www.revistas.usp.br/reeusp/article/view/134927 doi:ttp://dx.doi.org/10.1590/S1980-220X2017000003220

Cortes ALB, Silvino ZR. Fatores associados a interações medicamentosas potenciais em um Centro de Terapia Intensiva: estudo transversal. Esc Anna Nery [Internet]. 2019 [cited 2020 ago 29];23(3):1-9. Available from: https://www.scielo.br/scielo.php?pid=S1414-81452019000300204&script=sci_arttext&tlng=pt doi:http://dx.doi.org/10.1590/2177-9465-ean-2018-0326

Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian Intensive Care Unit. Indian J Crit Care Med [Internet]. 2016 [cited 2020 ago 29];20(2): 24-29. Available from: https://www.ijccm.org/doi/pdf/10.4103/0972-5229.175931

Rehr CA, Wong A, Seger DL, Bates DW. Determining inappropriate medication alerts from “inaccurate warning” overrides in the intensive care unit. Applied Clin inform [Internet]. 2018[cited 2020 ago 29]; 9(2): 268-27. Available from: https://sci-hub.tw/10.1055/s-0038-1642608

Grissinger M. Analysis of reported drug interactions: A recipe for harm to patients. Pa Pat Saf Advis [Internet]. 2016 [cited 2020 ago 29];13(4):137-48. Available from: http://patientsafety.pa.gov/ADVISORIES/documents/201612_137.pdf

Caribé RA, Chaves GR, Pocognoni JD, Souza IA. Potenciales interacciones medicamentosas en pacientes con sepsis internados en la unidad de terapia intensiva. Farmacia Hospitalaria [Internet]. 2013 [cited 2020 ago 29];37(5):383-387.Available from: http://scielo.isciii.es/pdf/fh/v37n5/07original05.pdf

Vieira LB, Reis AMM, Carvalho REFL, Faria LMP, Caassiani SHB. Interações medicamentosas potenciais em pacientes de Unidades de Terapia Intensiva. Rev Cienc Farm Básica Apl [Internet]. 2012 [cited 2020 ago 29]; 33(3):401-408. Available from: http://rcfba.fcfar.unesp.br/index.php/ojs/article/view/277/275

Silva UDA, Soeiro CLS, Resque RL, Gomes MRF, Costa ÉRG, Fujishima MAT, et al. Interações medicamentosas e consequentes intervenções farmacêuticas na Unidade de Terapia Intensiva de um hospital privado em Macapá, Amapá. Rev Soc Cienc Tecnol [Internet]. 2018 [cited 2020 ago 29];6(2):29-37. Available from: https://sci-hub.tw/https://doi.org/10.22239/2317-269x.00922

doi: https://doi.org/10.22239/2317-269x.00922

Rodrigues AT, Stahlschmidt R, Granja S, Pilger D, Falcão ALE, Mazzola PG. Prevalência de potenciais interações medicamentosas na unidade de terapia intensiva de um hospital de ensino brasileiro. Rev Bras Ciênc Farma [Internet]. 2017 [ cited 2020 ago 29];53(1): 1-8. Available from: https://www.scielo.br/pdf/bjps/v53n1/2175-9790-bjps-53-01-e16109.pdf doi:http://dx.doi.org/10.1590/s2175-97902017000116109

Rajkomar A, Blandford A. Understanding infusion administration in the ICU through distributed cognition. J Biomed Informa [Internet]. 2012 [cited 2020 ago 29]; 45(3):580-590. Available from: https://sci-hub.tw/https://doi.org/10.1016/j.jbi.2012.02.003

Ferreira Neto CJB, Plodek CK, Soares FK, Andrade RA, Teleginski F, Rocha MD. Intervenções farmacêuticas em medicamentos prescritos para administração via sondas enterais em hospital universitário. Rev Latino-Americana Enferm [Internet]. 2016 [cited 2020 ago 29];24:1-9. Available from: https://www.scielo.br/pdf/rlae/v24/pt_0104-1169-rlae-24-02696.pdf doi:10.1590/1518-8345.0619.2696




URN: http://www.jsncare.uff.br/index.php/jsncareurn:nbn:de:1983-4152jsncare.v13i1.33786

Bookmark and Share


JSNCARE
Share |